PROCEPT BioRobotics Reports Board Elections at June 9, 2026 Annual Meeting

What Happened
PROCEPT BioRobotics Corporation filed an 8-K on June 10, 2026 reporting results from its annual meeting held June 9, 2026. All director nominees named in the company’s April 22, 2026 proxy were elected to the board to serve until the 2029 annual meeting (or until a successor is elected). The company’s selection of PricewaterhouseCoopers LLP (PwC) as independent registered public accounting firm for 2026 was ratified. A non-binding advisory vote to approve the compensation of the company’s named executive officers was also approved.

Key Details

• Meeting date and filing: Annual meeting held June 9, 2026; Form 8-K filed June 10, 2026.
• Director election vote totals:
  • Antal Desai — For: 28,444,121; Withheld: 8,511,185; Broker Non-Votes: 10,418,057
  • Mary Garrett — For: 29,150,610; Withheld: 7,804,696; Broker Non-Votes: 10,418,057
  • Frederic Moll, M.D. — For: 36,455,610; Withheld: 499,696; Broker Non-Votes: 10,418,057
• Auditor ratification (Proposal 2): PwC approved — For: 47,328,539; Withheld: 21,691; Abstentions: 23,133.
• Advisory executive compensation vote (Proposal 3): Approved — For: 26,984,867; Withheld: 9,924,704; Abstentions: 45,735; Broker Non-Votes: 10,418,057.

Why It Matters

• Board composition confirmed: Election results finalize the board through 2029, which affects corporate oversight and strategic direction.
• Auditor continuity: Ratifying PwC keeps the same independent auditor for 2026, relevant for continuity in financial reporting and audits.
• Pay vote passed (non-binding): The advisory approval indicates shareholder support for the company’s executive compensation program, though it is not legally binding.
• Voting dynamics: The filing shows notable withheld votes and a substantial number of broker non-votes (10,418,057) on several proposals — useful context for investors tracking shareholder support and governance trends.